A new study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms ...
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback